Our Experts

Physician Profile

412-692-6740 Phone
412-692-6752 Fax

Mark T. Vander Lugt, MD

Mark Vander Lugt, MD
4401 Penn Avenue, Suite Floor 9
Pittsburgh, PA 15224
412-692-6740 Phone
412-692-6752 Fax

Education and Training

Medical School:

2006 Medical College of Wisconsin, Milwaukee, Wis.


2009 Department of Pediatrics, Children's Hospital of Wisconsin/Medical College of Wisconsin Affiliated Hospitals, Milwaukee, Wis.


2012 Division of Pediatric Hematology/Oncology, Department of Pediatrics and Communicable Diseases, CS Mott Children's Hospital, University of Michigan, Ann Arbor, Mich.



  • American Association of Immunologists (AAI), Trainee Membership
  • American Academy of Pediatrics (AAP), Post-residency Training Member

Board Certifications

  • American Board of Pediatrics, Diplomat


  • 2012 Best Abstracts Award for Basic Science, 2012 BMT Tandem meeting
  • 2011 Fellow Award for Clinical Investigation/Health Services Research, University of Michigan Pediatric Research Symposium
  • 2011 AAI Young Investigator Award, Autumn Immunology Conference, 40th Autumn Immunology Conference
  • 2011 ASH Abstract Achievement Award, 53rd Annual Meeting, American Society of Hematology
  • 2010-2012 Pediatric Molecular Hematology Research Training Grant, NIH


  • Yanik GA, Mineishi S, Levine JE, Kitko CL, White ES, Vander Lugt M, Harris AC, Braun T, and Cooke KR. Soluble Tumor Necrosis Factor Receptor: Enbrel (Etanercept) for Sub-Acute Pulmonary Dysfunction following Allogeneic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation 2011. Epub ahead of print. PMID: 22155140
  • Ferrara JL, Harris AC, Greenson JK, Braun TM, Holler E, Teshima T, Levine JE, Choi SW, Huber E, Landfried K, Akashi K, Vander Lugt M, Reddy P, Chin A, Zhang Q, Hanash S, Paczesny S. Regenerating islet-derived 3 alpha is a biomarker of gastrointestinal graft-versus-host disease. Blood, 2011; 118(25): 6702-8.
  • Chen A, Vander Lugt, M, McAllister-Lucas LM, Killen PD, Blatt, NB. An unusual case of membranous nephropathy associated with an ovarian tumor. Pediatric Nephrology, 2011; 26(12): 2249-51.

Research Interests

Dr. Vander Lugt’s research has focused on the discovery and validation of biomarkers of acute graft-versus-host disease. Using a proteomic analysis of plasma from patients undergoing bone marrow transplantation, he was involved in the discovery of a new biomarker for the diagnosis of gastrointestinal graft-versus-host disease, and also in the discovery of a biomarker, ST2, that can predict which patients will respond to graft-versus-host disease therapy and subsequent non-relapse mortality following transplantation. Currently, his work is focused on transplantation for non-malignant conditions.

Active Research Projects / Grants

  • Biomarkers of Graft vs. Host Disease
Last Update
December 16, 2014
  • Increase/Decrease Text Size
  • Print This Page
Last Update
December 16, 2014